Novartis and Pharmax collaborate to enhance access to quality medicines across UAE, in alignment with MOHAP’s strategy

• Strategic partnership between both organizations to serve UAE’s healthcare vision and enhance patient access to medication in key therapeutic areas such as diabetes and hypertension

• “Collaborations such as these will strengthen the UAE’s healthcare vision to bring high-quality medicines in the country – and accelerate our position as a regional hub for medical practices, therapies, treatments, and pharmaceutical industries,” said H.E. Dr Amin Hussein Al Amiri, Assistant Undersecretary for Public Health Policy and Licensing at the Ministry of Health and Prevention.